Saturday, November 28, 2015

Avid moves, but stays in Philadelphia

The start-up working on a compound to help diagnose Alzheimer's disease began in the University City Science Center four years ago. It's staying in West Philadelphia for now.

Avid moves, but stays in Philadelphia


Thirty years ago, a start-up biotechnology company set up labs in the University City Science Center to be close to the Wistar Institute, from which it had licensed monoclonal antibody technology.

But the allure of such proximity wasn’t strong enough to keep Centocor Inc. in West Philadelphia for long. Within three years, it had moved its labs and 70 employees to a 30,000-square-foot building in Malvern.

It’s a pattern that’s been repeated many times as companies start in the science center’s business incubator only to leave for cheaper, bigger space in the suburbs.

Last week, one firm bucked the trend. Having outgrown its 5,000 square feet at the science center, Avid Radiopharmaceuticals Inc. made its move - across Market Street.

Avid and its 37 employees are now in 16,000 square feet of office and lab space at 3711 Market St., the newest building in the science center’s research park.

Avid CEO Daniel M. Skovronsky looked at suburban labs, but remained urban for three reasons: He wanted to be near the University of Pennsylvania campus, where he’d worked before founding Avid in 2005. The location is easily accessible for employees. And he likes his landlord.

Like so many businesspeople before, Skovronsky cited the wage tax as perhaps the biggest drawback to staying in the city. And the commute from the suburbs can be a bear sometimes.

But overall, West Philadelphia is where Avid wants to be as it pursues Phase III clinical trials of a radioactive compound that lights up plaque in the brain to help diagnose Alzheimer’s disease. Avid hopes to complete that late-stage testing early next year.

Drug companies usually head for the suburbs because there simply hasn’t been the kind of lab space they need in the city. That’s something the science center is trying to change, said its president and CEO, Stephen S. Tang.

“Our vision has been West Philadelphia, the University City part, should be more like Cambridge, Mass., and Mission Bay, San Francisco,” said Tang, mentioning two tech-business magnets.

Philadelphia is a long way from such critical mass. But perhaps a bit of karma was involved. After all, Avid had occupied Centocor’s original incubator space. As successful as what is now Centocor Ortho Biotech has become, we’ll see what destiny has in store for Avid.

Inquirer Columnist
We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy: comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
comments powered by Disqus
About this blog
Mike Armstrong blogs about Philadelphia corporations and business-related topics. Contact him at 215-854-2980. Reach Mike at

Mike Armstrong Inquirer Columnist
Also on
letter icon Newsletter